StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) stock

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)

Close on Nov 17, 2026Market cap $172.35MP/E –Yield –

ADC Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ADC Therapeutics's market cap was $203.90M on Nov 11, 2026, against $484.29M a year earlier. Over the last 5 years it ranged from $56.20M to $1.55B, with a median of $283.93M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$203.90M-48.7%
2025Dec 31, 2025$397.57M+106.6%
2024Dec 31, 2024$192.41M+42.6%
2023Dec 29, 2023$134.88M-54.5%
2022Dec 30, 2022$296.55M-80.9%
2021Dec 31, 2021$1.55B-7.0%
2020Dec 31, 2020$1.67B–

More ADC Therapeutics figures

See a number that looks wrong?